Obatoclax Mesylate (GX15-070)

Catalog No.S1057

Obatoclax Mesylate (GX15-070) Chemical Structure

Molecular Weight(MW): 413.49

Obatoclax Mesylate (GX15-070) is an antagonist of Bcl-2 with Ki of 0.22 μM in a cell-free assay, can assist in overcoming MCL-1 mediated resistance to apoptosis. Phase 3.

Size Price Stock Quantity  
In DMSO USD 190 In stock
USD 170 In stock
USD 320 In stock
USD 870 In stock

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

9 Customer Reviews

  • In vivo antitumor efficacies of AZD2281 and GX15-070 alone or in combination in a BxPC-3 xenograft model. Tumor specimens were fixed in 10% formalin, embedded in paraffin, and cut into 4 lm-thick slides for H&E, PCNA, and CD34 staining.

    Cancer Lett 2014 348, 20-8. Obatoclax Mesylate (GX15-070) purchased from Selleck.

    Gx15-070 induces autophagy and necroptosis in TET cells. Time-course electron microscopic morphology of T1682 cells treated with Gx15-070 at the indicated concentrations. After 1-h treatment, lamellar bodies (yellow arrow) consistent with early signs of autophagy and mitochondrial structural changes with loss of cristae (orange arrow) were evident. After 6-h treatment, early signs of necroptosis with intact nuclear envelope (top panel), and mitochondrial swelling with loss of mitochondrial matrix and cytoplasm vacuolization were observed (bottom panel). After 48-h treatment, late stages of necroptotic cell death (yellow arrow) and advanced stages of autophagy (orange arrow) were evident. The bottom panel depicts advanced stage of autophagic cell death with cytoplasmic vacuolization and lamellar bound structures consistent with autophagosomes.

    Cell Death Dis 2012 19, 3:e351. Obatoclax Mesylate (GX15-070) purchased from Selleck.

  • ffect of Gx15-070 of mTOR pathway and on AMPKα. Effect of 6h Gx15-070 treatment on T1682 cells compared with untreated cells and cells starved for 6 h. The treatment induced a progressive reduction of p-AKT (Ser473 and Thr308) and p-RPS6 with the exception of 500 nM concentration. Progressive increase of LC3B-II and AMPKα phosphorylation was observed in Gx15-070 concentration-dependent manner.

    Cell Death Dis 2012 19, 3:e351. Obatoclax Mesylate (GX15-070) purchased from Selleck.

     

    Upregulation of A1 is crucial for resistance to ABT-737. The role of different anti-apoptotic Bcl-2 factors in determining resistance to ABT-737 was investigated, comparing the pro-apoptotic effect of ABT-737, antimycin A and obatoclax on activated (filled circles) and non-activated (open circles) BM3.3 CD8 T cells. T-cell activation induced resistance to ABT-737 and to antimycin A, but not to obatoclax, demonstrating a crucial role of A1 in this phenomenon. Percentage of cells treated with DMSO-containing vehicle is given. Half maximal inhibitory concentration (IC50) and 95% confidence interval (95% CI) are reported in the table.

    Cell death dis 2012 3, e299. Obatoclax Mesylate (GX15-070) purchased from Selleck.

  • HUH6 cells (C-H) were incubated with and without 10 ng/ml TNF-α and obatoclax at 0.1, 0.3 uM. Fewer mitochondria with an intact membrane potential were observed in JC-1 staining when obatoclax and TNF-α were added to the culture. Reddish points indicate the aggregation of JC-1 in intact mitochondria, and missing of reddish points indicate the start of apoptosis.

    Exp Cell Res 2014 322, 217-25. Obatoclax Mesylate (GX15-070) purchased from Selleck.

    Cell proliferation assays were carried out in SET-2 cells treated with increasing concentrations of NVP-BSK805 (empty triangles/solid line), obatoclax (filled squares/dotted line) or NVP-BSK805 in combination with a fixed obatoclax concentration of 700 nM (filled triangles/stippled line) for 72 hours.

     

     

    BMC Cancer 2011 11, 24. Obatoclax Mesylate (GX15-070) purchased from Selleck.

  • MEF cells were treated for  24 hours with the Bcl-2 antagonists  Obatoclax Mesylate at the indicated doses.Acute survival was monitored by replacing the drug-containing media with normal media and incubating the cells until visible colonies formed.Clonogenic survival is expressed relative to the numbers of colonies formed following 24 hours incubation in normal media(lacking drugs).

     

     

    Dr. Christine Hawkins of La Trobe University. Obatoclax Mesylate (GX15-070) purchased from Selleck.

    MDB-MA-231 cells were exposed to 30 μM cisplatin in the absence or in thepresence of 1 μM Obatoclax Mesylate .The cell were stained with Hoechst 33342,MitoTracker Red and Yo-pro-1.

     

     

    Dr. Zhang of Tianjin Medical University. Obatoclax Mesylate (GX15-070) purchased from Selleck.

  • Obataclax triggers cell death similarly in parental and ABT-737-resistant cells. Parental and ABT-R cells were treated with obataclax (Nalm-6 and Nalm-6 ABT-R: 10 uM; Reh and Reh ABT-R: 5 uM) for 18 h. (A) Cell viability was determined by trypan blue exclusion assay. (B) Mcl-1, NOXA, Bim, and b-actin as a loading control were analyzed by immunoblot. 

    Obatoclax Mesylate (GX15-070) purchased from Selleck.

Purity & Quality Control

Choose Selective Bcl-2 Inhibitors

Click to view more

Notes:

2. For more details, such as half maximal inhibitory concentrations (IC50s) and working concentrations of each inhibitor, please click on the link of the inhibitor of interest.
3. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation.
4. Orange "√" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

Biological Activity

Description Obatoclax Mesylate (GX15-070) is an antagonist of Bcl-2 with Ki of 0.22 μM in a cell-free assay, can assist in overcoming MCL-1 mediated resistance to apoptosis. Phase 3.
Features Potential 1st-in-class small molecule antagonist of Bcl-2 designed to inhibit all relevant Bcl-2 family members, including Mcl-1.
Targets
Bcl-2 [1]
(Cell-free assay)
0.22 μM(Ki)
In vitro

Obatoclax completely inhibits Bak recovery of Mcl-1 at 5 μM in SK-Mel5 cells and overcomes resistance to ABT-373-induced apoptosis conferred by Mcl-1 in KB/Bcl-2 cells. [1] Obatoclax is a BH3 mimetic which binds to a broad spectrum of Bcl-2 family members, including Bcl-2, Bcl-xL, and Mcl-1. Obatoclax uniquely displaces BH3 domains by activation of the pocket of Mcl-1 followed by a triggering of apoptosis mediated by oligomerization of Bak and release of cytochrome c. Obatoclax is sensitive to Bcl-xL in cell lines lacking it or showing low expression. It shows low cytotoxicity to Mcl-1, Bcl-2, and Bcl-xL in all the strongly-expressed cell lines. Obatoclax inhibits multiple myeloma (MM) cell lines (KMS12PE, KMS18, MY5, etc.) with IC50 values ranging from 52 to 1100 nM and the inhibition is umimpaired even in the presence of IL-6 or IGF-1, which are resistance to cytotoxic agents, at a concentration of 150 nM. Obatoclax enhances the antimyeloma activity induced by melphalan, dexamethasone, or bortezomib. [2] Obatoclax potentiates TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-mediated apoptosis by unsequestering Bak and Bim from Bcl-2/Bcl-xL or Mcl-1 proteins in PANC-1 and BxPC-3 cells. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
KARPAS-45 MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUPJR|UxRTBwMECwNFMyPyEQvF2= MVPTRW5ITVJ?
SK-MEL-30 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnnTTWM2OD1yLkCwNFM2PSEQvF2= NYHhepdJW0GQR1XS
NALM-6 NYflPFM3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVy3ZXJmUUN3ME2wMlAxODN3NjFOwG0> M{S5dXNCVkeHUh?=
KYSE-450 Ml25S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmjvTWM2OD1yLkCwNFQ3QSEQvF2= NXT6WXZiW0GQR1XS
BHY NFPCSFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEPUOFFKSzVyPUCuNFAxPjBzIN88US=> NHLBO|hUSU6JRWK=
GR-ST M3fs[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MU\JR|UxRTBwMECwOlQ5KM7:TR?= Mk\yV2FPT0WU
786-0 MlXjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MofHTWM2OD1yLkCwNFc4PiEQvF2= Mn;sV2FPT0WU
C-33-A M4Drfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVXJR|UxRTBwMECwPFQ5KM7:TR?= MVLTRW5ITVJ?
BHT-101 M3S0S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIfxbJJKSzVyPUCuNFAyODZizszN NYj4fYJ[W0GQR1XS
EB2 NUfiXld3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmH3TWM2OD1yLkCwNVE5KM7:TR?= NGqxc5BUSU6JRWK=
G-361 Ml\ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHX6UG1KSzVyPUCuNFAyOjRizszN MYPTRW5ITVJ?
KE-37 M3fJWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlvOTWM2OD1yLkCwNVI5KM7:TR?= NGTtRYdUSU6JRWK=
MHH-PREB-1 M4rtOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUTJR|UxRTBwMECxOEDPxE1? NE\VXmpUSU6JRWK=
MCF7 M{ThWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVjJR|UxRTBwMECxOVkh|ryP NIPZbGhUSU6JRWK=
LOUCY MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M37lZ2lEPTB;MD6wNFE4PSEQvF2= NF3nTpZUSU6JRWK=
EW-7 NIfKc5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGXkZ2FKSzVyPUCuNFAyPzVizszN NWrSdmMyW0GQR1XS
KYSE-510 NV;u[odRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnXiTWM2OD1yLkCwNlM{KM7:TR?= M4TnbHNCVkeHUh?=
SK-MEL-3 Mm\mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmezTWM2OD1yLkCwNlY1KM7:TR?= Mm\LV2FPT0WU
HAL-01 Ml\2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXPJR|UxRTBwMECyPVch|ryP NULPT2p{W0GQR1XS
HCC2998 NV34dZVzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYHJR|UxRTBwMECzN|Uh|ryP NWfCRoZIW0GQR1XS
A375 NX:0cpVJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1izOGlEPTB;MD6wNFM2KM7:TR?= NWr0V4FKW0GQR1XS
MZ7-mel MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVvJR|UxRTBwMECzPVkh|ryP MYrTRW5ITVJ?
SH-4 M3LZR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHi3SG9KSzVyPUCuNFA1OTdizszN NY\QeFhzW0GQR1XS
HT-144 NH7GcWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWTJR|UxRTBwMEC0N{DPxE1? MXPTRW5ITVJ?
KYSE-140 NEe4XJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX7KTYNUUUN3ME2wMlAxPDN3IN88US=> M1XI[XNCVkeHUh?=
PSN1 MmjDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFSxeGlKSzVyPUCuNFA1PjdizszN M2OxXHNCVkeHUh?=
COLO-679 NEHiTFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYXJR|UxRTBwMEC0PVgh|ryP MmrRV2FPT0WU
SW620 NEPRU2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVPJR|UxRTBwMEC1NVEh|ryP NGDzXG9USU6JRWK=
HGC-27 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MknsTWM2OD1yLkCwOVI1KM7:TR?= NYDGfmRUW0GQR1XS
IGROV-1 Mn;US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYHJR|UxRTBwMEC2JO69VQ>? MULTRW5ITVJ?
IGR-1 NEHlOnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIrIbmJKSzVyPUCuNFA3ODFizszN NGr0WGNUSU6JRWK=
EW-1 MmHnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUTu[mhIUUN3ME2wMlAxPjVzIN88US=> M{W3dnNCVkeHUh?=
769-P NI\0Z5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1\TbmlEPTB;MD6wNFY4QCEQvF2= NWjBeHZkW0GQR1XS
HN MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYjJR|UxRTBwMEC2O|kh|ryP MlzUV2FPT0WU
SIG-M5 M{DB[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEPKXotKSzVyPUCuNFA4OSEQvF2= NXXUfIU2W0GQR1XS
IST-MEL1 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2qye2lEPTB;MD6wNFgyQCEQvF2= MnrPV2FPT0WU
ST486 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoHiTWM2OD1yLkCwPFI2KM7:TR?= Mo\5V2FPT0WU
ES7 Ml7LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFPkUZZKSzVyPUCuNFA5PDZizszN MlTXV2FPT0WU
GAK NWj1UIR{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmTXTWM2OD1yLkCwPFQ5KM7:TR?= NGS1UVNUSU6JRWK=
BB30-HNC MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGKzWJFKSzVyPUCuNFA5PThizszN NEHMfItUSU6JRWK=
IPC-298 MnrFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MknxTWM2OD1yLkCwPVI4KM7:TR?= M{mwfHNCVkeHUh?=
NKM-1 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmfMTWM2OD1yLkCwPVczKM7:TR?= NVi4OGlIW0GQR1XS
RKO M2mxemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWPJR|UxRTBwMEGwOFQh|ryP NIru[3dUSU6JRWK=
ACN NYjtWZRDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4rmbmlEPTB;MD6wNVE{OSEQvF2= NIjYRZZUSU6JRWK=
SW1417 NGn2PW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NITMOlNKSzVyPUCuNFEzOjVizszN M1zLc3NCVkeHUh?=
SR MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWnZXHh2UUN3ME2wMlAyOjN3IN88US=> M{HCcHNCVkeHUh?=
SNG-M MmqzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4i1SmlEPTB;MD6wNVMyPyEQvF2= MWjTRW5ITVJ?
CAL-12T MoTzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3K4bmlEPTB;MD6wNVM1PiEQvF2= Ml7VV2FPT0WU
HSC-3 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoLCTWM2OD1yLkCxN|U2KM7:TR?= MUPTRW5ITVJ?
DOHH-2 NXTXOGp6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlvOTWM2OD1yLkCxOFEzKM7:TR?= NIroNldUSU6JRWK=
NB69 NX2yT3p4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MknlTWM2OD1yLkCxOVY2KM7:TR?= M3r6fnNCVkeHUh?=
LC-2-ad NG\5bYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NULMVGhZUUN3ME2wMlAyPThzIN88US=> M1fGdHNCVkeHUh?=
RVH-421 NYfme496T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFzHemZKSzVyPUCuNFE3PzRizszN MlXtV2FPT0WU
TGW M{LBTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYfJR|UxRTBwMEG3N|kh|ryP MlrqV2FPT0WU
HCC1569 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXyyR4x[UUN3ME2wMlAyPzl5IN88US=> MULTRW5ITVJ?
CAL-85-1 MlLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkPJTWM2OD1yLkCxPFMzKM7:TR?= MlHMV2FPT0WU
RPMI-8402 NIPRVZFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{Xhb2lEPTB;MD6wNVg2QCEQvF2= MlnmV2FPT0WU
THP-1 NVPEOoRHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIfqW|VKSzVyPUCuNFE6QThizszN MmLCV2FPT0WU
ONS-76 MmLLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnfsTWM2OD1yLkCyNFM3KM7:TR?= NF\nZYdUSU6JRWK=
A2780 Mly4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mlz3TWM2OD1yLkCyNFc6KM7:TR?= M1zIRnNCVkeHUh?=
RPMI-2650 M1W0U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3W2WmlEPTB;MD6wNlI6PiEQvF2= NUTpcXRyW0GQR1XS
MEL-HO MlywS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M37Kc2lEPTB;MD6wNlM1QCEQvF2= Ml24V2FPT0WU
MC-CAR NYDyZmRlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlvJTWM2OD1yLkCyN|U3KM7:TR?= MlK4V2FPT0WU
HSC-2 NYLDV3A6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWTDeo9DUUN3ME2wMlAzPDZ4IN88US=> NH7ufnJUSU6JRWK=
MEL-JUSO MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEDqfHZKSzVyPUCuNFI1PzNizszN M1:xPXNCVkeHUh?=
CAL-62 Ml21S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NU\PfWRiUUN3ME2wMlAzPjB{IN88US=> MYfTRW5ITVJ?
DMS-273 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4rLdWlEPTB;MD6wNlg1PyEQvF2= MmTrV2FPT0WU
S-117 NH;pfJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml23TWM2OD1yLkCyPVA3KM7:TR?= NWH2[oxZW0GQR1XS
SUP-T1 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{TCU2lEPTB;MD6wNlk1QSEQvF2= MmLhV2FPT0WU
MZ2-MEL NXLWUGtlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFjMNppKSzVyPUCuNFI6PTlizszN MnTxV2FPT0WU
KYSE-270 MkHIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVvJR|UxRTBwMEK5O|Yh|ryP NIPLPYlUSU6JRWK=
CMK M2qySGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXTCTGczUUN3ME2wMlA{ODJ|IN88US=> NUPiW4JQW0GQR1XS
8505C NFHt[YZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUPidFE5UUN3ME2wMlA{ODRizszN NYfZNpp1W0GQR1XS
NUGC-3 NVf6ZlJOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVrJR|UxRTBwMEOwOFgh|ryP MlPhV2FPT0WU
A101D M3jkR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVXxcFhjUUN3ME2wMlA{ODV3IN88US=> MmnMV2FPT0WU
G-401 NVfUXmR5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHyxXJJKSzVyPUCuNFMxQTNizszN NW\URW1VW0GQR1XS
OVCAR-8 NUK3UYM2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2DmUmlEPTB;MD6wN|ExPyEQvF2= Ml2zV2FPT0WU
IMR-5 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV23[|FuUUN3ME2wMlA{OjR2IN88US=> Ml\YV2FPT0WU
DoTc2-4510 NHG4WIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVf0ZWl5UUN3ME2wMlA{Ozl|IN88US=> MVvTRW5ITVJ?
HOS M{WyS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHHmSlBKSzVyPUCuNFM1PzNizszN NUnYTG5GW0GQR1XS
HEC-1 M1jvTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M13iWGlEPTB;MD6wN|Y5KM7:TR?= MmTtV2FPT0WU
SW756 M{LtNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWjJR|UxRTBwMEO4NlEh|ryP NUe3Z2g2W0GQR1XS
NCI-H64 M{fV[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVm5PHRMUUN3ME2wMlA{QDR{IN88US=> MXHTRW5ITVJ?
EW-16 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4r4b2lEPTB;MD6wN|kxQSEQvF2= MVTTRW5ITVJ?
CAL-51 Mm\YS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnOyTWM2OD1yLkC0NFA2KM7:TR?= M3vqPHNCVkeHUh?=
KYSE-150 NY\6V4tPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXjYRoE1UUN3ME2wMlA1ODFzIN88US=> M4TaeHNCVkeHUh?=
SW1710 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYTJR|UxRTBwMESwNVgh|ryP NF31SYRUSU6JRWK=
HuP-T4 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3H2TWlEPTB;MD6wOFEyQCEQvF2= NX;OVVFnW0GQR1XS
LB373-MEL-D NFLXSolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmK3TWM2OD1yLkC0NlMzKM7:TR?= MXXTRW5ITVJ?
EW-13 M2Xhfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVzJR|UxRTBwMES0NFYh|ryP NYPMR|dNW0GQR1XS
HT-29 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYfrZ4cyUUN3ME2wMlA1PDlizszN Mn7hV2FPT0WU
SCC-25 Mk\WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVLT[mFnUUN3ME2wMlA1PDl2IN88US=> MU\TRW5ITVJ?
REH M1TlXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4nOfWlEPTB;MD6wOFY{PSEQvF2= MYfTRW5ITVJ?
L-363 M{PzU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWrpPIdoUUN3ME2wMlA1Pjd7IN88US=> M4HHSXNCVkeHUh?=
NCI-H1770 NX3tXYJ6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYXJR|UxRTBwMES2PVch|ryP MVLTRW5ITVJ?
CHL-1 NIe5VY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX\qOlB4UUN3ME2wMlA1QDV5IN88US=> Mlr6V2FPT0WU
ES1 M4PkOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEDC[pJKSzVyPUCuNFQ5QDVizszN NXXDSHhtW0GQR1XS
SCC-15 NVHjOXZGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFrVeHNKSzVyPUCuNFQ6ODJizszN M4HDXHNCVkeHUh?=
MRK-nu-1 NVjYbY9vT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXnJR|UxRTBwMES5N|Yh|ryP NUTnNJRLW0GQR1XS
PF-382 NULoTHBiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEXYZpJKSzVyPUCuNFQ6OzlizszN NUS1[XBuW0GQR1XS
COLO-680N NHnPSHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3;WUWlEPTB;MD6wOVA1PyEQvF2= MWjTRW5ITVJ?
LK-2 NILU[FNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MorKTWM2OD1yLkC1NFY{KM7:TR?= M3T3e3NCVkeHUh?=
NCI-H2342 NWOwWJJKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYjJR|UxRTBwMEWxNVch|ryP NH;mZVhUSU6JRWK=
HMV-II NEO4U3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGL1NmdKSzVyPUCuNFUzOzlizszN NGDE[JBUSU6JRWK=
PC-14 M4Htfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXrJR|UxRTBwMEWyOVIh|ryP MorUV2FPT0WU
COLO-320-HSR M2rYcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NE\JWYxKSzVyPUCuNFUzQDlizszN NHzOTldUSU6JRWK=
697 M1[wS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHn3dY9KSzVyPUCuNFU{OjNizszN MkjSV2FPT0WU
NEC8 M1;VXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{P4fWlEPTB;MD6wOVU6KM7:TR?= MlO5V2FPT0WU
LCLC-97TM1 MkXFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mk\sTWM2OD1yLkC1OVk1KM7:TR?= NGfPb|hUSU6JRWK=
Daoy NXnN[VA5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1;DeWlEPTB;MD6wOVYyPiEQvF2= MnrhV2FPT0WU
ETK-1 M2m1[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGL3NldKSzVyPUCuNFU3PzJizszN MYXTRW5ITVJ?
A388 NH;4eZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIHic5lKSzVyPUCuNFU3QTVizszN NUTuNXNYW0GQR1XS
COLO-205 MoPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4rLT2lEPTB;MD6wOVcyPiEQvF2= M4jHOHNCVkeHUh?=
SK-PN-DW MnHES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmD5TWM2OD1yLkC1O|I6KM7:TR?= MnPLV2FPT0WU
SF268 NHXoUIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWe4SVZ{UUN3ME2wMlA2PzV4IN88US=> M3jXW3NCVkeHUh?=
OCI-AML2 MkPNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYXSRndNUUN3ME2wMlA2Pzd5IN88US=> NInTT5FUSU6JRWK=
GAMG M{DvR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVXJR|UxRTBwMEW4JO69VQ>? NVfyZ3plW0GQR1XS
BCPAP NUG1U2VZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYTWVIZXUUN3ME2wMlA2QDl{IN88US=> M{\JSXNCVkeHUh?=
BC-1 NWLlZmhIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVjaN4ZFUUN3ME2wMlA3ODJ{IN88US=> MUnTRW5ITVJ?
IA-LM MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUK2S5ROUUN3ME2wMlA3ODV|IN88US=> MVfTRW5ITVJ?
NCI-H1299 Mn\TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M17yOWlEPTB;MD6wOlE{KM7:TR?= MVfTRW5ITVJ?
COR-L23 M1z5S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUHJR|UxRTBwME[xN|Qh|ryP NHfVN29USU6JRWK=
KYSE-180 NWPUb|ZpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWXJR|UxRTBwME[xOFIh|ryP NETzUW5USU6JRWK=
LOXIMVI MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXS1RmxbUUN3ME2wMlA3OTh6IN88US=> Moi4V2FPT0WU
BL-41 M3Xjdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYHJR|UxRTBwME[yNVkh|ryP NV3UUGRYW0GQR1XS
BL-70 M4KzSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVXrOVdXUUN3ME2wMlA3OzB{IN88US=> NUTrbWs5W0GQR1XS
NOS-1 NH3kd3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M125eWlEPTB;MD6wOlQyOSEQvF2= MmXvV2FPT0WU
NB13 NEO4ZnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1rwUmlEPTB;MD6wOlQzOSEQvF2= M3X0V3NCVkeHUh?=
CAL-27 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHXWbllKSzVyPUCuNFY1PjRizszN M1;k[HNCVkeHUh?=
CA46 NWLvd3Z1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFnTPZlKSzVyPUCuNFY2OzdizszN MkL4V2FPT0WU
SW962 NWn6eIdJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3S1VWlEPTB;MD6wOlU3QSEQvF2= M323eXNCVkeHUh?=
NCI-H226 Mn\sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{fMU2lEPTB;MD6wOlY{OiEQvF2= M2T6ZnNCVkeHUh?=
KYSE-70 NEX5XFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUfWSm9VUUN3ME2wMlA3QTR3IN88US=> M1PKO3NCVkeHUh?=
Daudi MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NISz[GtKSzVyPUCuNFcxQDFizszN MkOxV2FPT0WU
SW626 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUGxeYFkUUN3ME2wMlA4OjB2IN88US=> M1fsW3NCVkeHUh?=
ESS-1 NVL3RlJrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1u1SGlEPTB;MD6wO|I1PiEQvF2= MWPTRW5ITVJ?
YT MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1ftcmlEPTB;MD6wO|M1PSEQvF2= MV\TRW5ITVJ?
P12-ICHIKAWA MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{PYUWlEPTB;MD6wO|M1QSEQvF2= NVLIe|FVW0GQR1XS
BxPC-3 M3XWcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmjQTWM2OD1yLkC3OFU5KM7:TR?= NETx[|hUSU6JRWK=
CTV-1 M1nNdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGTGVXlKSzVyPUCuNFc2OTdizszN NG\EeFVUSU6JRWK=
MLMA M3TURmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHvNblhKSzVyPUCuNFc2OzRizszN M3\NWnNCVkeHUh?=
WSU-NHL MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3rBdWlEPTB;MD6wO|U2PCEQvF2= NHz3NVVUSU6JRWK=
CTB-1 NIL1cIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWjJR|UxRTBwMEe1PFgh|ryP M2DUV3NCVkeHUh?=
MMAC-SF MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2SybWlEPTB;MD6wO|Y3QCEQvF2= M4Xk[HNCVkeHUh?=
8-MG-BA NWXmbZBFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{XhNGlEPTB;MD6wO|gxOSEQvF2= NH7HdYVUSU6JRWK=
NCI-H358 M{DkSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGHH[oxKSzVyPUCuNFc5PzlizszN MV7TRW5ITVJ?
BFTC-905 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGf0R3pKSzVyPUCuNFc6ODlizszN MnTiV2FPT0WU
NCI-H727 MnzyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoDvTWM2OD1yLkC4NFU{KM7:TR?= NIGyfG1USU6JRWK=
CHP-212 NILqRoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF3pU|hKSzVyPUCuNFgxQTVizszN MnvhV2FPT0WU
HOP-62 MmH1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHT6fmtKSzVyPUCuNFgzPDVizszN M3WyNnNCVkeHUh?=
CESS MkHBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mo\aTWM2OD1yLkC4NlY6KM7:TR?= MXTTRW5ITVJ?
HuCCT1 NFzrVoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYHwZ2pbUUN3ME2wMlA5OzN|IN88US=> NIPnNWJUSU6JRWK=
DEL MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXnJR|UxRTBwMEizOFch|ryP NGLTRXJUSU6JRWK=
5637 MkC0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVjJR|UxRTBwMEizOlch|ryP MYTTRW5ITVJ?
RS4-11 NHzHPFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHzWNmFKSzVyPUCuNFg1QTdizszN NVrzeZpHW0GQR1XS
KURAMOCHI M37H[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVnOT25rUUN3ME2wMlA5PTB7IN88US=> MVfTRW5ITVJ?
A427 NIjCOldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVvEdZd{UUN3ME2wMlA5PTF{IN88US=> MYDTRW5ITVJ?
A3-KAW Mlm3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEDvZ4tKSzVyPUCuNFg2PjZizszN M3XDWHNCVkeHUh?=
LS-123 MlXBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF\LNZdKSzVyPUCuNFg4OTlizszN NFPYT2JUSU6JRWK=
LoVo M3G1Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX;oOWxLUUN3ME2wMlA5PzJizszN M2ex[nNCVkeHUh?=
PA-1 M1fqcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NInRfFdKSzVyPUCuNFg4PjlizszN NIruSHFUSU6JRWK=
CP50-MEL-B NXq1[ItqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYnJR|UxRTBwMEi3PVMh|ryP Ml3oV2FPT0WU
A431 NWrTOFF3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV;JR|UxRTBwMEi4NFEh|ryP NXzWNmdQW0GQR1XS
HCT-116 NUfEbIttT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4PLTGlEPTB;MD6wPFgxOiEQvF2= MWjTRW5ITVJ?
A4-Fuk M1nFWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUfpRYY6UUN3ME2wMlA5QTR5IN88US=> MVfTRW5ITVJ?
RPMI-6666 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVTQXoJbUUN3ME2wMlA5QTZ5IN88US=> NYi0XVh3W0GQR1XS
Calu-6 NH7LV3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYXH[Gx[UUN3ME2wMlA6ODJ7IN88US=> MojuV2FPT0WU
KMOE-2 NXzmS4tmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{nPbGlEPTB;MD6wPVA{QSEQvF2= NWq2[ZAyW0GQR1XS
A704 NYjtb5NNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWHj[oF1UUN3ME2wMlA6OTVizszN MYLTRW5ITVJ?
HO-1-N-1 NIXSWGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVHKUZM4UUN3ME2wMlA6OjR7IN88US=> M{jUcnNCVkeHUh?=
NCI-H2122 NXO0NpRrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX3JR|UxRTBwMEmzO|gh|ryP M17W[HNCVkeHUh?=
U-698-M M3q5Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{nUdGlEPTB;MD6wPVQxQSEQvF2= NFPJboVUSU6JRWK=
IST-SL2 MknvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{S0[WlEPTB;MD6wPVQ3QCEQvF2= NVHFZ5VEW0GQR1XS
TE-10 NEK2SYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4\CeWlEPTB;MD6wPVU5PCEQvF2= M2S3SXNCVkeHUh?=
PANC-03-27 Mnq2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml\YTWM2OD1yLkC5OlcyKM7:TR?= MoGzV2FPT0WU
KYSE-410 MnrqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWjJR|UxRTBwMEm3PVch|ryP NFrHO|BUSU6JRWK=
TE-8 MmjDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEC5bohKSzVyPUCuNFk5QDVizszN NYe4Npg2W0GQR1XS
MN-60 M1TFfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkTyTWM2OD1yLkC5PFk4KM7:TR?= MUXTRW5ITVJ?
NCI-H460 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2PPS2lEPTB;MD6xNFA6KM7:TR?= NVr6eYtJW0GQR1XS
LB771-HNC NFr5XYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn\1TWM2OD1yLkGwNlU2KM7:TR?= M4\ZSXNCVkeHUh?=
ES4 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4fRVGlEPTB;MD6xNFI3PCEQvF2= MlLjV2FPT0WU
HUTU-80 MnX4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF7zPZhKSzVyPUCuNVA{PjVizszN Mk\6V2FPT0WU
647-V MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHPVSGpKSzVyPUCuNVA1ODhizszN NEnCb4pUSU6JRWK=
HTC-C3 M4H3N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1L5OWlEPTB;MD6xNFQ{OiEQvF2= NHPVR5hUSU6JRWK=
NTERA-S-cl-D1 MoW2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mm\ITWM2OD1yLkGwOFQ5KM7:TR?= NXTIV2hpW0GQR1XS
A2058 NXjhfHY5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NInOc|hKSzVyPUCuNVA3PTVizszN MV;TRW5ITVJ?
MZ1-PC NUHTRoFYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWPJR|UxRTBwMUC4N{DPxE1? NEWySWVUSU6JRWK=
J82 NF;BTYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXPibpJYUUN3ME2wMlExQDh2IN88US=> MVjTRW5ITVJ?
ARH-77 NGLxV3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWj2NI5oUUN3ME2wMlEyKM7:TR?= M1jWZnNCVkeHUh?=
Ca9-22 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NW\iXm46UUN3ME2wMlEyOTJ6IN88US=> MYHTRW5ITVJ?
NCI-H1648 M2C0bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVzJR|UxRTBwMUGyPFYh|ryP Mlf0V2FPT0WU
MC116 NGTQZ3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml7NTWM2OD1yLkGxN|M4KM7:TR?= M1jnSnNCVkeHUh?=
EoL-1-cell NWHSWZI6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWjJR|UxRTBwMUG0Olch|ryP Ml;XV2FPT0WU
PANC-10-05 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGj6WplKSzVyPUCuNVE1QTFizszN M135Z3NCVkeHUh?=
SF539 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUHyTZJMUUN3ME2wMlEyPjF4IN88US=> NYXqPVVwW0GQR1XS
ES8 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mmn0TWM2OD1yLkGxOlM{KM7:TR?= M3zXNHNCVkeHUh?=
NCI-H810 M4PTfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NETUcZNKSzVyPUCuNVE3PjRizszN NH62W3FUSU6JRWK=
J-RT3-T3-5 NETUeoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWXJR|UxRTBwMUG3OUDPxE1? NXnv[llrW0GQR1XS
NY NGHBbZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV3JR|UxRTBwMUG4NVch|ryP NIW0PGNUSU6JRWK=
NCI-SNU-1 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEfNfJRKSzVyPUCuNVIyPDhizszN MlXZV2FPT0WU
EFM-19 M2rqT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX3JR|UxRTBwMUKzO|Qh|ryP NHrjRmVUSU6JRWK=
HCC1806 NGL5dHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3j0SWlEPTB;MD6xNlM5OyEQvF2= M1fDTXNCVkeHUh?=
HCE-T NEPvZ3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWPDcWNIUUN3ME2wMlEzPTNzIN88US=> M1rWSnNCVkeHUh?=
HT-1376 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWnLS215UUN3ME2wMlEzPjZ6IN88US=> M1TTfnNCVkeHUh?=
BE-13 NGW0OnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYjJR|UxRTBwMUK4OlYh|ryP Mkj4V2FPT0WU
NCI-H520 NF;PO|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlvBTWM2OD1yLkGyPFY4KM7:TR?= NHu3fZNUSU6JRWK=
SK-MES-1 MlfSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXzJR|UxRTBwMUK5NVMh|ryP MXPTRW5ITVJ?
SNU-423 NWTlWYdiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MonMTWM2OD1yLkGyPVE1KM7:TR?= NYj2Olh2W0GQR1XS
Ramos-2G6-4C10 NFn3TZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWTJR|UxRTBwMUK5NVYh|ryP M1q4RXNCVkeHUh?=
EW-18 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmX5TWM2OD1yLkGzNFI3KM7:TR?= NEjZVnlUSU6JRWK=
NCI-H2087 MnnwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1LSeWlEPTB;MD6xN|AzPyEQvF2= Mn\aV2FPT0WU
COLO-792 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{PvXWlEPTB;MD6xN|E3PSEQvF2= MUfTRW5ITVJ?
QIMR-WIL M3;NfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUDpPI1QUUN3ME2wMlE{OjJ|IN88US=> MXfTRW5ITVJ?
ACHN NVTNW4lFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NG\ZWJpKSzVyPUCuNVMzPDdizszN M3fHeHNCVkeHUh?=
RPMI-8866 NUTqR2p{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIG5dIdKSzVyPUCuNVMzPjFizszN MkDsV2FPT0WU
SK-LU-1 NV:wRlFRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mmr0TWM2OD1yLkGzOFQ6KM7:TR?= NGjDN3BUSU6JRWK=
SK-UT-1 M1\4fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUPJR|UxRTBwMUO2Nlgh|ryP M1f6VHNCVkeHUh?=
MFE-296 NEPhcW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGHtU2ZKSzVyPUCuNVM5PjRizszN MVfTRW5ITVJ?
RD MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXPJR|UxRTBwMUO5PVch|ryP NHPHdpJUSU6JRWK=
LS-411N NGX0THpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVzROY9jUUN3ME2wMlE1Ojl3IN88US=> M2f6eXNCVkeHUh?=
NCI-H747 M{L5cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX7WSXlEUUN3ME2wMlE1OyEQvF2= M1rEZ3NCVkeHUh?=
ES6 NVzXTGQyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV7JR|UxRTBwMUSzOkDPxE1? NUDtW49pW0GQR1XS
TE-1 NVXPeFN1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVLZ[pk5UUN3ME2wMlE1PDB5IN88US=> M3e1PXNCVkeHUh?=
SJSA-1 NEHTfGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGDWepNKSzVyPUCuNVQ4ODdizszN MWnTRW5ITVJ?
NCI-H1355 M{LpXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGHJWmZKSzVyPUCuNVUzQTNizszN NXXGO3ZKW0GQR1XS
HEL MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1HPdWlEPTB;MD6xOVQ1PyEQvF2= NGi3blBUSU6JRWK=
639-V MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYPJR|UxRTBwMUW1PVYh|ryP M4LOOXNCVkeHUh?=
AN3-CA M3rLbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHvqenVKSzVyPUCuNVU3OzlizszN NGHm[JNUSU6JRWK=
SK-MEL-2 NWPKNZBKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M16wemlEPTB;MD6xOVY3QCEQvF2= M3G4R3NCVkeHUh?=
SW872 NH7CbIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV3CZVh2UUN3ME2wMlE3ODR{IN88US=> NVLTN5l2W0GQR1XS
DU-4475 NEnnbZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX3ubXVoUUN3ME2wMlE3OTZ{IN88US=> NGTxVnJUSU6JRWK=
YKG-1 Ml:yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{jRSmlEPTB;MD6xOlI4OyEQvF2= M3zGNnNCVkeHUh?=
GT3TKB NUPKVJRZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUCyVYtpUUN3ME2wMlE3Ojh|IN88US=> M1\NcnNCVkeHUh?=
GB-1 NUDIOnJVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIDsSodKSzVyPUCuNVY1OjRizszN NIK2WXFUSU6JRWK=
KARPAS-422 Mk\kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmLVTWM2OD1yLkG2OVc1KM7:TR?= MkmxV2FPT0WU
ATN-1 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{T0OmlEPTB;MD6xOlY2PiEQvF2= M{\PbnNCVkeHUh?=
HLE NIX5foZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{WzSWlEPTB;MD6xOlg4PyEQvF2= NYjMU2ZLW0GQR1XS
D-542MG M{nvOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFvzcplKSzVyPUCuNVY6QDZizszN MmXrV2FPT0WU
EB-3 M3\6Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmC2TWM2OD1yLkG3N|Eh|ryP MmXSV2FPT0WU
HCC1143 MkfqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGnEUYJKSzVyPUCuNVc{QTZizszN NY\5R21GW0GQR1XS
DJM-1 M3\Q[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MU\JR|UxRTBwMUe0OVEh|ryP MU\TRW5ITVJ?
BT-474 MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVjFfooxUUN3ME2wMlE4PDh7IN88US=> M4P2T3NCVkeHUh?=
BB65-RCC NWC0NYtiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIHWR|NKSzVyPUCuNVc2PDVizszN NWP6dZZZW0GQR1XS
NCI-H292 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYHkTmlqUUN3ME2wMlE4PjBzIN88US=> MWfTRW5ITVJ?
MKN28 NHLUNpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYLJR|UxRTBwMUe2OVMh|ryP MYnTRW5ITVJ?
TK10 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXXJR|UxRTBwMUe3NFIh|ryP NUP3cGdJW0GQR1XS
TYK-nu NFLaR3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV\JR|UxRTBwMUe5OFkh|ryP MU\TRW5ITVJ?
8305C MnvSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUjJR|UxRTBwMUe5O|Eh|ryP MV\TRW5ITVJ?
MV-4-11 MoroS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXXSNnFxUUN3ME2wMlE4QTd5IN88US=> NUHkOJpWW0GQR1XS
NCI-H522 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M13ydGlEPTB;MD6xPFA6PCEQvF2= NETPdYNUSU6JRWK=
Hs-578-T Ml\kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlH0TWM2OD1yLkG4NlkzKM7:TR?= MWPTRW5ITVJ?
LCLC-103H NFnXcJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2LQ[mlEPTB;MD6xPFUzPyEQvF2= M4fhfHNCVkeHUh?=
MHH-ES-1 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1nSXGlEPTB;MD6xPFYzQSEQvF2= MoPyV2FPT0WU
NCI-H441 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoHwTWM2OD1yLkG5NVQ5KM7:TR?= MYTTRW5ITVJ?
AM-38 NGjH[4tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M372SGlEPTB;MD6xPVIzPSEQvF2= M325ZnNCVkeHUh?=
SW1783 Ml3lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXLoUI9KUUN3ME2wMlE6OzB3IN88US=> NGL1OYRUSU6JRWK=
SK-HEP-1 NXTCN457T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NU[yZXpqUUN3ME2wMlE6PjN5IN88US=> NGexcopUSU6JRWK=
OAW-28 NX;0UmJuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M37rbGlEPTB;MD6yNFE4QCEQvF2= NGPlfGlUSU6JRWK=
TE-15 M1XM[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVi3cFdyUUN3ME2wMlIxOjV{IN88US=> NXrQZ|lnW0GQR1XS
HCE-4 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF7KVXhKSzVyPUCuNlAzQDRizszN NUDTXFBpW0GQR1XS
JiyoyeP-2003 M2\Pbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUTJR|UxRTBwMkCzN|Yh|ryP NFL2[HdUSU6JRWK=
OVCAR-4 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWXVSGFuUUN3ME2wMlIxPjJ6IN88US=> NGfkNGFUSU6JRWK=
SNU-449 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MofwTWM2OD1yLkKwO|k4KM7:TR?= Ml\IV2FPT0WU
SBC-5 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVvJR|UxRTBwMkGyNVUh|ryP NWfiVW56W0GQR1XS
T84 NWjub4lDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUTJR|UxRTBwMkGyOFgh|ryP M1HLfHNCVkeHUh?=
LP-1 NEfmZnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX3JR|UxRTBwMkGzNFIh|ryP NGrBZ45USU6JRWK=
MG-63 MmL4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkDITWM2OD1yLkKxN|gzKM7:TR?= Ml33V2FPT0WU
OAW-42 M2X4NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlH0TWM2OD1yLkKxOFc5KM7:TR?= NUDBN3hkW0GQR1XS
L-540 M2P1eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml7RTWM2OD1yLkKxOVk5KM7:TR?= NHz4b|FUSU6JRWK=
RH-1 M3jXTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGLofFZKSzVyPUCuNlIzPDJizszN M2XsT3NCVkeHUh?=
HCT-15 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MW\JR|UxRTBwMkK0PFQh|ryP MVjTRW5ITVJ?
OCUB-M NIjFSnVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlTsTWM2OD1yLkKyOFg5KM7:TR?= MYfTRW5ITVJ?
GP5d M4TXXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXftXoc5UUN3ME2wMlIzPTJ6IN88US=> MlTqV2FPT0WU
NCI-H2030 NE[yVlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3z4[mlEPTB;MD6yNlc{PCEQvF2= M3fZXXNCVkeHUh?=
ML-2 NEDYUnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVG3RmpIUUN3ME2wMlIzQDh7IN88US=> MW\TRW5ITVJ?
CAL-39 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVHJR|UxRTBwMkK5N|Yh|ryP NIDyNIpUSU6JRWK=
MIA-PaCa-2 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF;KWFRKSzVyPUCuNlMzQDdizszN MUfTRW5ITVJ?
TE-9 NHnaSYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXLXfHVNUUN3ME2wMlI{OzJizszN NWTJe|lqW0GQR1XS
LB2518-MEL M1jkbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4LRTmlEPTB;MD6yN|M4OiEQvF2= MmfPV2FPT0WU
DB NH[xdZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX7JR|UxRTBwMkO0N|gh|ryP NYn4PHF7W0GQR1XS
NCI-H596 NV6wd5pzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkfMTWM2OD1yLkKzOVcyKM7:TR?= MVrTRW5ITVJ?
SW1990 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXnJR|UxRTBwMkO5OFYh|ryP MkjPV2FPT0WU
P30-OHK NIL4cYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYrJR|UxRTBwMkSwOUDPxE1? NH3pcmpUSU6JRWK=
ALL-PO NGHQfYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYfDWGRqUUN3ME2wMlI1OTZ7IN88US=> MorMV2FPT0WU
Saos-2 NFj0NpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHPoU41KSzVyPUCuNlQ2PzFizszN M1fYTHNCVkeHUh?=
MFH-ino M1jp[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnrhTWM2OD1yLkK0OlkzKM7:TR?= NIXZbZlUSU6JRWK=
OE33 NF;Vd5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MY\JR|UxRTBwMkWxNUDPxE1? MW\TRW5ITVJ?
Calu-3 NWfrO41RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVXJR|UxRTBwMkWyPVch|ryP NInUd|BUSU6JRWK=
HT NHXkR|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEKz[FVKSzVyPUCuNlU3OjFizszN MV7TRW5ITVJ?
LXF-289 M3vSZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGLpOoZKSzVyPUCuNlU6QDRizszN M3\NV3NCVkeHUh?=
KGN MmDmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NX\NZ4MzUUN3ME2wMlI3ODh7IN88US=> NXf1VZA4W0GQR1XS
NCI-H1417 NV6yPVMzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3ywe2lEPTB;MD6yOlUzPCEQvF2= MYrTRW5ITVJ?
SF126 Ml\zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{f5ZmlEPTB;MD6yO|MxOiEQvF2= MVTTRW5ITVJ?
SAS MlLtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYLOT4pTUUN3ME2wMlI4OzB6IN88US=> NYPSOm12W0GQR1XS
22RV1 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoPjTWM2OD1yLkK3N|c5KM7:TR?= Mmn2V2FPT0WU
GI-1 NY\pXHJ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NES1[GFKSzVyPUCuNlc1QDdizszN M3ntdnNCVkeHUh?=
ES3 M2TDb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1\RcWlEPTB;MD6yO|c3OyEQvF2= MV3TRW5ITVJ?
NB1 NYT4cpF5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1;TR2lEPTB;MD6yO|g4PiEQvF2= MYHTRW5ITVJ?
NCI-H650 M4DqeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVrJR|UxRTBwMkizNFIh|ryP NVXLOIg2W0GQR1XS
IST-MES1 M4TMWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnPmTWM2OD1yLkK4OVU1KM7:TR?= M3zMcnNCVkeHUh?=
UM-UC-3 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIfr[FhKSzVyPUCuNlkyPCEQvF2= MkX4V2FPT0WU
CAL-120 NGjG[JNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEDjTlhKSzVyPUCuNlk3OzFizszN Mne5V2FPT0WU
UACC-62 M1jFcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF6ycYtKSzVyPUCuN|AzPDFizszN M1fMWnNCVkeHUh?=
TE-11 NYT6Vm1CT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUDJR|UxRTBwM{CyOFkh|ryP MljRV2FPT0WU
MKN1 NYPadJJmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXPJR|UxRTBwM{CzOkDPxE1? NX\WUXFoW0GQR1XS
KS-1 M17HVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVi4Upl6UUN3ME2wMlMxPTJ4IN88US=> NYjwcJM1W0GQR1XS
GCIY NV3vVppiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFfBcJlKSzVyPUCuN|ExODJizszN M2CyUnNCVkeHUh?=
OVCAR-5 M{f6UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MW\JR|UxRTBwM{GxNFYh|ryP MoLKV2FPT0WU
U-266 NX;lW3JlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYHy[|R[UUN3ME2wMlMyOTR5IN88US=> MoHPV2FPT0WU
Calu-1 M{TLWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml\DTWM2OD1yLkOxNlg6KM7:TR?= MVTTRW5ITVJ?
SK-LMS-1 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIq2[5NKSzVyPUCuN|E1OjlizszN MVLTRW5ITVJ?
COLO-741 NUXpcYZ[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M33IOGlEPTB;MD6zNVYyPCEQvF2= M3rVVHNCVkeHUh?=
RPMI-8226 NHLDO|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUDJR|UxRTBwM{G2OFEh|ryP M1PzTHNCVkeHUh?=
KM12 NG\JUWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmDxTWM2OD1yLkOxPFMh|ryP NU\lfItPW0GQR1XS
NMC-G1 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX\jem1qUUN3ME2wMlMyQDZizszN NXPweI4zW0GQR1XS
SJRH30 NV7MXXJkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{[4T2lEPTB;MD6zNlA2OiEQvF2= Mm\KV2FPT0WU
COR-L105 NIm1N5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmnYTWM2OD1yLkOyNlE5KM7:TR?= MkHlV2FPT0WU
IM-9 MlPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXzJR|UxRTBwM{OwNlEh|ryP NULzbYlNW0GQR1XS
TE-12 MlvlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWTJR|UxRTBwM{OzNVch|ryP MVHTRW5ITVJ?
KG-1 NWDQd5duT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVjJR|UxRTBwM{O0N|Ih|ryP MnK3V2FPT0WU
U251 NWq0S5ppT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYXRT|AxUUN3ME2wMlM{PDV4IN88US=> NV;weZJmW0GQR1XS
EFO-27 MmrHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NG\YR|JKSzVyPUCuN|M6PTFizszN MX;TRW5ITVJ?
EW-24 M4DVc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{LYcWlEPTB;MD6zN|k5PCEQvF2= MmqyV2FPT0WU
SF295 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3\aeWlEPTB;MD6zN|k6QSEQvF2= MlrqV2FPT0WU
MC-IXC NGTGUlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFjjOldKSzVyPUCuN|Q2KM7:TR?= MmrOV2FPT0WU
NCI-H2405 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV\4ZnN5UUN3ME2wMlM1PzN{IN88US=> NH;6ZlRUSU6JRWK=
NCI-H2009 NH;LZY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MofUTWM2OD1yLkO0O|M6KM7:TR?= MVXTRW5ITVJ?
LB1047-RCC MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mo\NTWM2OD1yLkO1PFE2KM7:TR?= MnHhV2FPT0WU
KNS-81-FD Mn\lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1ToZ2lEPTB;MD6zOlY3PyEQvF2= MVHTRW5ITVJ?
HOP-92 Ml;qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlTOTWM2OD1yLkO2PFMh|ryP MWXTRW5ITVJ?
L-428 NEXFO4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoX1TWM2OD1yLkO3NFE3KM7:TR?= M4ewOnNCVkeHUh?=
C3A NVzYV4JVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4HmXmlEPTB;MD6zO|M4QSEQvF2= M2nXPXNCVkeHUh?=
NCI-H1792 NEX4UmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MorxTWM2OD1yLkO3OlU2KM7:TR?= NH60elBUSU6JRWK=
HuH-7 Ml7SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mm[wTWM2OD1yLkO3PVEh|ryP M3r2SXNCVkeHUh?=
AGS M4K0dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2D6fWlEPTB;MD6zPFY{QCEQvF2= M3vFXHNCVkeHUh?=
HT-1197 NFLJZXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF7XUGpKSzVyPUCuN|k1PiEQvF2= MWTTRW5ITVJ?
CGTH-W-1 Ml;PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWjldIRwUUN3ME2wMlM6QTF|IN88US=> NVLlXZlMW0GQR1XS
KNS-42 M2CyO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYXPWppXUUN3ME2wMlQxODR3IN88US=> NWLIOHI1W0GQR1XS
HuO-3N1 M3;vZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHvPcY9KSzVyPUCuOFAxPTVizszN MljyV2FPT0WU
VMRC-RCZ M4DybGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1r2ZmlEPTB;MD60NFMxOyEQvF2= NUD3UWs6W0GQR1XS
SW954 NGDIeZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWrDXHpMUUN3ME2wMlQxOzN3IN88US=> MVHTRW5ITVJ?
MES-SA M3THbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2LyXGlEPTB;MD60NFUxPSEQvF2= M{n6V3NCVkeHUh?=
Ca-Ski MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFn3OWFKSzVyPUCuOFA2OjRizszN M1\ocHNCVkeHUh?=
SW13 NVy4Xo1sT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmDsTWM2OD1yLkSwOlI3KM7:TR?= MXPTRW5ITVJ?
NCI-H1437 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkWxTWM2OD1yLkSwPFA2KM7:TR?= NVvGTFFvW0GQR1XS
U-118-MG MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWPJR|UxRTBwNEC5NFQh|ryP M4rMcXNCVkeHUh?=
NCI-H1734 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M17TXmlEPTB;MD60NlAyOyEQvF2= NYDUXGtHW0GQR1XS
HDLM-2 MonjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkfQTWM2OD1yLkSyNFM{KM7:TR?= NIPlV45USU6JRWK=
AU565 MlXsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1qwVmlEPTB;MD60NlQ3QCEQvF2= M4XLeXNCVkeHUh?=
FADU MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1nPNWlEPTB;MD60NlY1QSEQvF2= NGT1XI5USU6JRWK=
OS-RC-2 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXfLT2lpUUN3ME2wMlQ{ODh|IN88US=> MlrOV2FPT0WU
CAMA-1 M{LJeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVrJR|UxRTBwNEO2NlYh|ryP NUTXOYpSW0GQR1XS
MONO-MAC-6 NEjnPFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4\4R2lEPTB;MD60N|g1QSEQvF2= NIrCW5RUSU6JRWK=
LB831-BLC NGOxfnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHOyeVVKSzVyPUCuOFQ{PzFizszN NYTuSm01W0GQR1XS
SW982 NW\kbXp[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYnqblNDUUN3ME2wMlQ1PTJ6IN88US=> NHW5cGpUSU6JRWK=
SCC-3 M2LNUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX3qVGJKUUN3ME2wMlQ1PTd7IN88US=> M2X5PHNCVkeHUh?=
C32 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHXCVZFKSzVyPUCuOFUzOjlizszN M33xSnNCVkeHUh?=
BFTC-909 NY\MWmh6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUHJR|UxRTBwNEWyPVkh|ryP MVTTRW5ITVJ?
MEG-01 MknRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3\5TGlEPTB;MD60OVM4OyEQvF2= MYPTRW5ITVJ?
M14 MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIDWSXVKSzVyPUCuOFU6PzlizszN NWnMfms3W0GQR1XS
MPP-89 M{jvRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlKxTWM2OD1yLkS2NlU3KM7:TR?= NH7y[4hUSU6JRWK=
HCC1937 M1PlUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3nZU2lEPTB;MD60OlM5PCEQvF2= MoTuV2FPT0WU
SW837 MoDLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnLzTWM2OD1yLkS2O|IzKM7:TR?= NXvER3B4W0GQR1XS
DU-145 MmrBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2PPSmlEPTB;MD60OlczQSEQvF2= NXW3XploW0GQR1XS
LB996-RCC NGflRlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH\kbHlKSzVyPUCuOFcxPTRizszN NXPuPI5tW0GQR1XS
C8166 MmTyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWLJR|UxRTBwNEe0JO69VQ>? NFLQWWdUSU6JRWK=
MOLT-4 M2PUXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEXocplKSzVyPUCuOFc4OzRizszN NXW1T2ZXW0GQR1XS
DMS-53 MnjsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF;vSnVKSzVyPUCuOFc5ODlizszN NE\GRY9USU6JRWK=
TE-5 NIDjZmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnW0TWM2OD1yLkS4N|A2KM7:TR?= MVjTRW5ITVJ?
KYSE-520 MoHxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M136bGlEPTB;MD60PFM1OyEQvF2= NXG5SFVPW0GQR1XS
Detroit562 NH:0SlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUXmNoFSUUN3ME2wMlQ5QDZizszN M4SzcHNCVkeHUh?=
SIMA M3T2cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWruS3B7UUN3ME2wMlQ6PDF5IN88US=> M2TOUXNCVkeHUh?=
NCI-H1651 NWryWpM3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXjJR|UxRTBwNEm2O{DPxE1? MWjTRW5ITVJ?
HCC1599 NYPRbow2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXLBVYR6UUN3ME2wMlQ6QTV3IN88US=> NFTLXGRUSU6JRWK=
ABC-1 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoLlTWM2OD1yLkWwOFk3KM7:TR?= Mo\xV2FPT0WU
CAL-33 NYO4NWRGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn74TWM2OD1yLkWwPFQ1KM7:TR?= MVjTRW5ITVJ?
OPM-2 NWLyOnBwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWDqOIl7UUN3ME2wMlUxQTN5IN88US=> MYHTRW5ITVJ?
RPMI-7951 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVnJR|UxRTBwNUC5OVch|ryP M124d3NCVkeHUh?=
HT-1080 NEn5SIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml\tTWM2OD1yLkWxNVE6KM7:TR?= NGKyOGZUSU6JRWK=
LC4-1 Mlr0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NETPOXJKSzVyPUCuOVE1ODNizszN Ml;FV2FPT0WU
OVCAR-3 NIDWW2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2TCO2lEPTB;MD61NVU4KM7:TR?= M1rjdnNCVkeHUh?=
CAPAN-1 NIDm[3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH30RYVKSzVyPUCuOVIzQDhizszN NHX2T5VUSU6JRWK=
SK-OV-3 NETEW|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXjNfHdDUUN3ME2wMlUzPDN2IN88US=> NH7FR29USU6JRWK=
HuP-T3 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2DXUmlEPTB;MD61NlgzPyEQvF2= MnfEV2FPT0WU
NCI-H838 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGPHVWRKSzVyPUCuOVI5PDlizszN M{DYbnNCVkeHUh?=
K5 NVnJNYduT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF7oclBKSzVyPUCuOVMzODFizszN NVnDTY5wW0GQR1XS
CAL-72 M{iwcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUPDS4Z7UUN3ME2wMlU{Ozh5IN88US=> M4T0PXNCVkeHUh?=
NH-12 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVn4cYpZUUN3ME2wMlU{QTV7IN88US=> NUTlV|F2W0GQR1XS
SNB75 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWHZO|FEUUN3ME2wMlU2PzNizszN NUnxVnBjW0GQR1XS
BPH-1 M{fWeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1q4bmlEPTB;MD61OlM1PCEQvF2= NFL6TJJUSU6JRWK=
NOMO-1 NFPOZZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUPscXIxUUN3ME2wMlU3Ozd{IN88US=> MmHxV2FPT0WU
G-402 NF\YeJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFruSXZKSzVyPUCuOVY1QTlizszN NFjWelVUSU6JRWK=
NCI-H2052 M33U[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUTJR|UxRTBwNU[3OFEh|ryP NEfvd5FUSU6JRWK=
RCM-1 M37yVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3THdWlEPTB;MD61O|E3PiEQvF2= M{TKdnNCVkeHUh?=
COR-L279 NF\DTXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MorLTWM2OD1yLkW3NVg2KM7:TR?= M3HpPXNCVkeHUh?=
A253 NUPaRYNjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2rDZmlEPTB;MD61O|UzPSEQvF2= NVjLfJN5W0GQR1XS
SK-MM-2 M3zKZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4m1VmlEPTB;MD61O|Y4QSEQvF2= MUnTRW5ITVJ?
NCI-H1703 M{HtXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MojSTWM2OD1yLkW5OFI4KM7:TR?= MWDTRW5ITVJ?
UACC-257 NXTZUFJDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MljSTWM2OD1yLkW5OFg4KM7:TR?= NYPMdYZ6W0GQR1XS
KALS-1 M4LhTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH3VV3hKSzVyPUCuOlAxOTFizszN MnXxV2FPT0WU
ES5 NUjDXJF7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mnu3TWM2OD1yLk[wOFgh|ryP Mk\BV2FPT0WU
MHH-CALL-2 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MknpTWM2OD1yLk[wPFg5KM7:TR?= MkXWV2FPT0WU
ChaGo-K-1 M{\m[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF\Zd2lKSzVyPUCuOlEzOjlizszN NXWwfVNiW0GQR1XS
TGBC1TKB MnrDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmfLTWM2OD1yLk[xPVgh|ryP MnjqV2FPT0WU
KU-19-19 NU\YTIhQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4rObmlEPTB;MD62OFU5PiEQvF2= MWTTRW5ITVJ?
COLO-684 MlnKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M17NOWlEPTB;MD62OVYyOSEQvF2= NULnOGtyW0GQR1XS
LS-1034 M1rKUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX3lWHNFUUN3ME2wMlY2QDF7IN88US=> NGjxR4RUSU6JRWK=
RT-112 M1TyVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4fDRWlEPTB;MD62OlU5PyEQvF2= MoL3V2FPT0WU
Capan-2 NWLqSJFET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWrJR|UxRTBwNk[2NlIh|ryP Ml7hV2FPT0WU
HSC-4 M1HCW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3PQVmlEPTB;MD62OlY6QCEQvF2= MWPTRW5ITVJ?
COLO-824 Mm\5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUfJR|UxRTBwNke4NlMh|ryP MWXTRW5ITVJ?
NCI-H2170 MnT2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1L2SWlEPTB;MD62PFI2QCEQvF2= MkXVV2FPT0WU
GDM-1 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn;UTWM2OD1yLk[4OFk1KM7:TR?= NWfTXIlvW0GQR1XS
KP-4 M4Twd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUHG[JoxUUN3ME2wMlY6PTd|IN88US=> MULTRW5ITVJ?
VA-ES-BJ NHeyVJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVfJb45QUUN3ME2wMlY6QTh4IN88US=> NHzIPJRUSU6JRWK=
KM-H2 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVjmeYhvUUN3ME2wMlcxODlzIN88US=> MoTSV2FPT0WU
HH NV7pVJkxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIT3XVFKSzVyPUCuO|A3PjJizszN NGr3PFVUSU6JRWK=
DK-MG MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFu0[llKSzVyPUCuO|ExOTZizszN Ml[zV2FPT0WU
VM-CUB-1 NHHOTHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlO2TWM2OD1yLkexNlU6KM7:TR?= NUTrNFAyW0GQR1XS
COLO-829 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnHiTWM2OD1yLkexPVg2KM7:TR?= M3nKUXNCVkeHUh?=
OMC-1 NViyPFhUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3zvcGlEPTB;MD63NlExPCEQvF2= MlLpV2FPT0WU
NB12 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4H3[mlEPTB;MD63NlUxPCEQvF2= M2HFNHNCVkeHUh?=
NCI-H28 NELLb2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYfQRoxEUUN3ME2wMlc1ODh|IN88US=> M1zpfHNCVkeHUh?=
A673 NVTrd4dLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUPVTW9lUUN3ME2wMlc2OTd5IN88US=> MYXTRW5ITVJ?
LB2241-RCC MlvoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkTuTWM2OD1yLke2NFg4KM7:TR?= MlzsV2FPT0WU
CCRF-CEM NVn0VphPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlPLTWM2OD1yLke3NFUzKM7:TR?= NGqzPGpUSU6JRWK=
NCI-H510A M4fhbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlqwTWM2OD1yLke3NVg3KM7:TR?= NYTQV5NUW0GQR1XS
SW48 NVnJXIc5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGLLNnRKSzVyPUCuO|c{OzNizszN NGH3TGlUSU6JRWK=
NCI-H2081 NWDsTXNuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV\JR|UxRTBwN{ixOFch|ryP NInUbZlUSU6JRWK=
RMG-I NXK3WY9QT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4XDTGlEPTB;MD63PFIyOiEQvF2= NFv0TZJUSU6JRWK=
LU-99A NF63Z2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHT5eGFKSzVyPUCuO|g1OTNizszN NWraU4loW0GQR1XS
KP-N-YS NVvSNHZYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M37EWGlEPTB;MD63PFkzOSEQvF2= MkP3V2FPT0WU
MDA-MB-231 NE\PSGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2rpWWlEPTB;MD64NFE{OSEQvF2= MXrTRW5ITVJ?
U031 NXWwVnV2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MljmTWM2OD1yLkixOFI{KM7:TR?= M2fhTXNCVkeHUh?=
EVSA-T M{TUTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUDJR|UxRTBwOEG2O|Ih|ryP M1PWdXNCVkeHUh?=
MDA-MB-157 NVP5dFNlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVrJR|UxRTBwOEKyO|Eh|ryP MV3TRW5ITVJ?
EHEB MkHUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1rZ[2lEPTB;MD64NlI4PiEQvF2= NYTlO|JRW0GQR1XS
KINGS-1 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mne1TWM2OD1yLkiyOVU2KM7:TR?= MUfTRW5ITVJ?
23132-87 M1q1emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWrJR|UxRTBwOEK4OFMh|ryP NUPzVJhGW0GQR1XS
EFO-21 MkjhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{LVRWlEPTB;MD64OFA5QSEQvF2= M3;1enNCVkeHUh?=
DOK M4TINmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3ewdmlEPTB;MD64OFgh|ryP NVX3bZZtW0GQR1XS
NCI-H2171 NF7CXHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MY\JR|UxRTBwOES5OkDPxE1? MmrSV2FPT0WU
NCI-SNU-5 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3rkbWlEPTB;MD64OVU4KM7:TR?= NF;uSoNUSU6JRWK=
SK-N-DZ NIDhVnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{KwUWlEPTB;MD64OVk1OyEQvF2= NFXQTIdUSU6JRWK=
SNU-C2B MkjhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmL3TWM2OD1yLki2PFAyKM7:TR?= NE\lV3NUSU6JRWK=
CP66-MEL M4raWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYLxTI5FUUN3ME2wMlg4OTFizszN Ml\nV2FPT0WU
SN12C NXTZVGI6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUXJR|UxRTBwOEi2N|ch|ryP NH6yT2FUSU6JRWK=
A172 MoTjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV\JR|UxRTBwOEi2PVgh|ryP MVPTRW5ITVJ?
NCI-H2347 NFfBVJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUDzXplQUUN3ME2wMlg5PzV|IN88US=> NXjvUXdpW0GQR1XS
NCI-H2228 Mn7NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHH1dXlKSzVyPUCuPFk{OzlizszN MYjTRW5ITVJ?
SNU-387 M2r2dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NW[xXVRrUUN3ME2wMlkxOjZ2IN88US=> NFu2OGFUSU6JRWK=
SK-MEL-24 M3q1fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEnEeZdKSzVyPUCuPVE{PDRizszN NVrGflVrW0GQR1XS
MDA-MB-468 NWTJXZloT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH;TfmVKSzVyPUCuPVE4OyEQvF2= M1m3dnNCVkeHUh?=
NCI-H1694 MkfRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVPJR|UxRTBwOUG4O|Yh|ryP MVjTRW5ITVJ?
CCF-STTG1 NYXPNo04T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4jNSGlEPTB;MD65NlY{PyEQvF2= Mnf0V2FPT0WU
K052 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1LtVWlEPTB;MD65OFA1PyEQvF2= NEfxVXFUSU6JRWK=
NCI-H446 NX22TZk4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVrJR|UxRTBwOUWwNUDPxE1? NIn2RnFUSU6JRWK=
MFE-280 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYjJR|UxRTBwOU[yPVEh|ryP NHu5[JFUSU6JRWK=
KU812 NGm0No1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYXJR|UxRTBwOUmzPFkh|ryP Ml:1V2FPT0WU
MDA-MB-361 M1fMXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlKxTWM2OD1yLkm5O|c4KM7:TR?= M4W0VnNCVkeHUh?=
Raji NUHxZ2lNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn63TWM2OD1zLkCyNlY4KM7:TR?= MlXsV2FPT0WU
TE-6 NILaXXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1XKXGlEPTB;MT6wN|U3PiEQvF2= MmDPV2FPT0WU
CAL-148 NXPZc41FT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF;1RmpKSzVyPUGuNFQ1PDNizszN NX7GOWpzW0GQR1XS
NCI-H1963 MoLJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkP4TWM2OD1zLkC0OVU{KM7:TR?= M1LJbnNCVkeHUh?=
SK-N-AS MmH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1yze2lEPTB;MT6wOFY5PSEQvF2= Mk\FV2FPT0WU
RERF-LC-MS MoH2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkXmTWM2OD1zLkC2N|Q6KM7:TR?= NFTzWWdUSU6JRWK=
BEN NIfOU5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUHqUoFWUUN3ME2xMlA4OTN5IN88US=> MVPTRW5ITVJ?
CAS-1 M2DmWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn;MTWM2OD1zLkC5NVI{KM7:TR?= MlezV2FPT0WU
SW780 NV\qeVlzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmSxTWM2OD1zLkC5NVgyKM7:TR?= Mn3YV2FPT0WU
LU-65 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MY\JR|UxRTFwMEm0NUDPxE1? MYPTRW5ITVJ?
D-283MED M2rzO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoX5TWM2OD1zLkGyNlczKM7:TR?= M1zTSXNCVkeHUh?=
HCC2157 M324Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXLESIN7UUN3ME2xMlE{PjR{IN88US=> M3nLcnNCVkeHUh?=
RCC10RGB M{KzOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVTtc41vUUN3ME2xMlE1ODB4IN88US=> M1Loc3NCVkeHUh?=
PLC-PRF-5 MkLNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnLRTWM2OD1zLkG1NlI6KM7:TR?= MnniV2FPT0WU
H4 NYHOPWV3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGHZVmlKSzVyPUGuNVU1OzlizszN MUXTRW5ITVJ?
TUR M124UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUTBeFNFUUN3ME2xMlE2PzV{IN88US=> NH;JdnFUSU6JRWK=
NCI-H2141 NX:0NFUyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1L6[GlEPTB;MT6xPFk1PiEQvF2= NGHVV5lUSU6JRWK=
PFSK-1 NVjTOohoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUHUcGpIUUN3ME2xMlIxPTN{IN88US=> M1S4[HNCVkeHUh?=
SK-MEL-28 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHPVenFKSzVyPUGuNlMzOjFizszN MWXTRW5ITVJ?
SCC-9 NGH4WYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX21RphiUUN3ME2xMlI{PjZ3IN88US=> NHzmbZFUSU6JRWK=
T47D NXvOSJpnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYDVbVl3UUN3ME2xMlI{Pjl4IN88US=> MoGwV2FPT0WU
TCCSUP M2\oUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX;HSWY{UUN3ME2xMlI2ODJ7IN88US=> M33JSXNCVkeHUh?=
SU-DHL-1 MmfjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmfaTWM2OD1zLkK1NVE5KM7:TR?= MmjxV2FPT0WU
HL-60 NXHDZY04T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M33keGlEPTB;MT6yOVU5QCEQvF2= NGnEfIRUSU6JRWK=
NCI-H1436 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1;NRWlEPTB;MT6yOlE1QSEQvF2= NX3ne29{W0GQR1XS
DMS-114 NHXTWJNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4PXR2lEPTB;MT6yOlY{OiEQvF2= MnfTV2FPT0WU
BOKU NEnVU2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkXmTWM2OD1zLkK4NFk2KM7:TR?= M3\OT3NCVkeHUh?=
MS-1 MkS4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIXjUFdKSzVyPUGuNlkxPjlizszN NVHUZoFVW0GQR1XS
NCI-H661 M2OwTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3q4dGlEPTB;MT6zNFQ4QCEQvF2= NETwe2VUSU6JRWK=
HT-3 NVHjbotTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmfoTWM2OD1zLkOwOVI6KM7:TR?= NEXYR2NUSU6JRWK=
CAL-54 M370WWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2nTS2lEPTB;MT6zNFczPSEQvF2= NXK5OndNW0GQR1XS
SW1463 MkTCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NX7rUXZlUUN3ME2xMlMyQDd{IN88US=> MUnTRW5ITVJ?
COLO-668 M{Lj[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3vMbWlEPTB;MT6zN|A2PiEQvF2= NG\IZVVUSU6JRWK=
PANC-08-13 NVu1dFh1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV\JR|UxRTFwM{O4NFMh|ryP NXGzWIM2W0GQR1XS
BB49-HNC MonvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnTtTWM2OD1zLkO0NFEh|ryP MVHTRW5ITVJ?
M059J MlPuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV3mWVMzUUN3ME2xMlM2QDN{IN88US=> M3[yNHNCVkeHUh?=
NCCIT NXHEPHpnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHe2T2RKSzVyPUGuN|c6QDhizszN NYPKVY1FW0GQR1XS
LN-405 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHjSVJJKSzVyPUGuN|kzPjRizszN MV3TRW5ITVJ?
UMC-11 Ml\uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M13yUmlEPTB;MT6zPVk6PiEQvF2= MoLkV2FPT0WU
NB5 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoW1TWM2OD1zLkSxNlI4KM7:TR?= Ml;pV2FPT0WU
TE-441-T M1HyeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MU\JR|UxRTFwNEK4NVch|ryP MVnTRW5ITVJ?
ME-180 M1TkPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MniwTWM2OD1zLkS0N|kzKM7:TR?= NEjQc4dUSU6JRWK=
HCC70 MlTXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH\5TG1KSzVyPUGuOFYxQTZizszN NWLBWlNKW0GQR1XS
no-10 NH3ob49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWPY[mxbUUN3ME2xMlQ3OThzIN88US=> NH76Z41USU6JRWK=
JEG-3 NVv2eGh2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUHJR|UxRTFwNUCxN|Ih|ryP NGLzd|BUSU6JRWK=
no-11 NIjSb2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3rK[mlEPTB;MT61NFg5OiEQvF2= NIDybINUSU6JRWK=
CHP-126 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mk[wTWM2OD1zLkW2OlkyKM7:TR?= NXTXb20zW0GQR1XS
EGI-1 NHLWbWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGfNXlVKSzVyPUGuOVgxOjVizszN M1raXHNCVkeHUh?=
D-392MG MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXnJR|UxRTFwNUm2N{DPxE1? MkfrV2FPT0WU
RT4 NH3DR5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYjDVJRqUUN3ME2xMlU6PjN5IN88US=> M3[2TXNCVkeHUh?=
A204 Mn3MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmrjTWM2OD1zLkW5PFAyKM7:TR?= MWXTRW5ITVJ?
NCI-H1304 NEj0VnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmrNTWM2OD1zLk[zOVkyKM7:TR?= NFq4SmxUSU6JRWK=
Becker M3ixSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmHFTWM2OD1zLk[0NlQyKM7:TR?= NYPoSWJpW0GQR1XS
OE19 NVrpUWRqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHmzVVhKSzVyPUGuOlU2OThizszN MmfxV2FPT0WU
EKVX MnrIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2jWcWlEPTB;MT62OVYyQCEQvF2= MlLJV2FPT0WU
KLE NH7mbmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWrJR|UxRTFwNkW3NVQh|ryP MXLTRW5ITVJ?
K-562 M3;5XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlXtTWM2OD1zLk[3NFM4KM7:TR?= Mn7CV2FPT0WU
MDA-MB-175-VII MkGxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NX;lcYxQUUN3ME2xMlY5QTl5IN88US=> MYXTRW5ITVJ?
NCI-H716 NHjYXGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mlm5TWM2OD1zLk[5N|A1KM7:TR?= MXnTRW5ITVJ?
Caov-3 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUDJR|UxRTFwNkm0NVMh|ryP MVrTRW5ITVJ?
HCC1187 NGno[HBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M37tVmlEPTB;MT63NFU1PSEQvF2= MUDTRW5ITVJ?
CAKI-1 NXnvfpdRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYTWeW5TUUN3ME2xMlczOjl{IN88US=> NVn0Nm1KW0GQR1XS
MOLT-16 NGG1[JlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXTKUlBRUUN3ME2xMlc{OzB5IN88US=> NXqxWlljW0GQR1XS
PC-3 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFznc2RKSzVyPUGuO|UxQCEQvF2= MYDTRW5ITVJ?
DV-90 M{fL[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkG2TWM2OD1zLke1OVg2KM7:TR?= NXryTWw4W0GQR1XS
RXF393 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXjJR|UxRTFwN{eyPVQh|ryP NGrh[XFUSU6JRWK=
SK-NEP-1 MlzhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4D4cGlEPTB;MT64NlM{QSEQvF2= MXPTRW5ITVJ?
HCC1419 M2PydWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXnESmVNUUN3ME2xMlgzPjl{IN88US=> MkfnV2FPT0WU
BV-173 NWHMWVFIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGTCW5FKSzVyPUGuPFI6QTVizszN Mn76V2FPT0WU
MKN7 MlzNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3rHT2lEPTB;MT64PVIzKM7:TR?= NH3kU5hUSU6JRWK=
LAN-6 NVfyblkyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{HZN2lEPTB;MT64PVU2OyEQvF2= NF7sOolUSU6JRWK=
Mo-T MlnVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlzRTWM2OD1zLkmwNFM6KM7:TR?= MlTZV2FPT0WU
HCC1395 NVXUXGtZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVi0S4hYUUN3ME2xMlkzQDZ|IN88US=> NVHsVXZ3W0GQR1XS
HC-1 NVrsSHhoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1TCRmlEPTB;MT65N|Q4KM7:TR?= MWnTRW5ITVJ?
HPAF-II MofwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{ToUWlEPTB;MT65OFQyQCEQvF2= M3XkcnNCVkeHUh?=
CPC-N MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1u0UWlEPTB;MT65PFAxOiEQvF2= MVzTRW5ITVJ?
MKN45 M3;GSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MW\JR|UxRTFwOUmxNVkh|ryP M1vGfnNCVkeHUh?=
NCI-H1693 NHToTG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWD2cZl7UUN3ME2yMlAxPDN|IN88US=> NIjYR3VUSU6JRWK=
SHP-77 MmHnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUHoeYlQUUN3ME2yMlAxPTN|IN88US=> Mnq4V2FPT0WU
NCI-H1522 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYnpOYVVUUN3ME2yMlAyPzJ2IN88US=> Mk\0V2FPT0WU
SW1573 NWHx[VI2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnzCTWM2OD1{LkCyNkDPxE1? MV7TRW5ITVJ?
DBTRG-05MG M1TMZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlrwTWM2OD1{LkC2NFg4KM7:TR?= NEC3[G5USU6JRWK=
SCC-4 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3Xk[2lEPTB;Mj6xOFMyKM7:TR?= M3XC[nNCVkeHUh?=
DMS-153 NYG1TFB4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3zISGlEPTB;Mj6xOlY3QCEQvF2= MWjTRW5ITVJ?
MDA-MB-415 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{fnVWlEPTB;Mj6xO|UzKM7:TR?= NF24No9USU6JRWK=
NCI-H2126 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2LHOGlEPTB;Mj6yNlg5QCEQvF2= NWGyZms{W0GQR1XS
MDA-MB-453 MlG4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGrNZmNKSzVyPUKuNlM{OiEQvF2= NHzJOGlUSU6JRWK=
U-87-MG M1f5fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV3GbmRCUUN3ME2yMlI5PTl{IN88US=> NV\PXm9kW0GQR1XS
LNCaP-Clone-FGC M1;ZXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHL5U|VKSzVyPUKuN|AyODJizszN MojiV2FPT0WU
NCI-H1581 NWHXRnJCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWjDcmpLUUN3ME2yMlMzOTB3IN88US=> MY\TRW5ITVJ?
BC-3 NFLPXGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYXG[mlpUUN3ME2yMlM3PTB7IN88US=> MULTRW5ITVJ?
HCC38 NVLTUIZ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVnJR|UxRTJwM{i0OFch|ryP MlnSV2FPT0WU
HCC2218 NHPKSGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4\YXmlEPTB;Mj60NFgxQSEQvF2= Mn\rV2FPT0WU
RO82-W-1 MmDlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWDoTIprUUN3ME2yMlQyOjVizszN NXjyT5RCW0GQR1XS
C2BBe1 M{LoXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVu5SXlFUUN3ME2yMlQyPTd6IN88US=> Mo\pV2FPT0WU
LAMA-84 M2L2dmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4H1bGlEPTB;Mj61O|M3QCEQvF2= NVvJWI17W0GQR1XS
GMS-10 M4\KTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{jrfmlEPTB;Mj61O|YyOSEQvF2= MX\TRW5ITVJ?
GCT MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnnlTWM2OD1{LkW4Olk1KM7:TR?= M1LicXNCVkeHUh?=
SK-CO-1 NG[3U5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4rDZmlEPTB;Mj62NVY3KM7:TR?= NFPvW3JUSU6JRWK=
NCI-H526 NYq3XIVXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkPjTWM2OD1{Lk[zOFUh|ryP M{fJW3NCVkeHUh?=
SW1088 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXXuWoJLUUN3ME2yMlc4QDN7IN88US=> MXzTRW5ITVJ?
HT55 NUizT25JT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVv2dGlZUUN3ME2yMlc5Pjl3IN88US=> NF7kdGlUSU6JRWK=
NB10 NWX2NWxZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWDJR|UxRTJwOEG3OFgh|ryP M4LS[XNCVkeHUh?=
UACC-893 NEPiPHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHLGXpJKSzVyPUKuPFU4PDlizszN Mo\xV2FPT0WU
NCI-H1618 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWPwZYZ2UUN3ME2yMlg5OTV|IN88US=> MlTyV2FPT0WU
NCI-H1092 M{TjS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3rBUWlEPTB;Mz6wO|gyOiEQvF2= MWHTRW5ITVJ?
SBC-1 MlzZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWXrNFZmUUN3ME2zMlA5PTV|IN88US=> NIXzZ2ZUSU6JRWK=
NCI-H1623 NVrHdI96T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH70bpBKSzVyPUOuNFk{PCEQvF2= MkfyV2FPT0WU
SiHa MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYHJR|UxRTNwMUG5O|ch|ryP MVvTRW5ITVJ?
D-263MG NWfOUIFUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHrB[ZVKSzVyPUOuNVQ4QDhizszN MXvTRW5ITVJ?
NCI-H1573 NHzTemdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{PqTmlEPTB;Mz6xPVY1OSEQvF2= M{nFU3NCVkeHUh?=
NCI-H82 NFrPN3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF7QTXJKSzVyPUOuN|Q1OzlizszN NILXfnFUSU6JRWK=
NCI-H2196 M2C3NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2PMeWlEPTB;Mz6zOVAxQCEQvF2= MUjTRW5ITVJ?
MFM-223 NX7tbGczT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGLuUVFKSzVyPUOuN|c{PTFizszN Mo\sV2FPT0WU
COLO-678 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3rQS2lEPTB;Mz6zPFE5PiEQvF2= M{DpTnNCVkeHUh?=
EW-3 MoLjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIL3eoxKSzVyPUOuOFA6PSEQvF2= MX;TRW5ITVJ?
MHH-NB-11 M2qweWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFnkU49KSzVyPUOuOFQxPjlizszN NVLMZ|N4W0GQR1XS
EM-2 M{S3Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWfJR|UxRTNwNkO5PEDPxE1? MU\TRW5ITVJ?
FTC-133 M3[yVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{jrXGlEPTB;Mz62OVQ2QCEQvF2= NXfhNVZxW0GQR1XS
NCI-H209 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXPxUVBHUUN3ME2zMlY4PjV|IN88US=> M4\YSXNCVkeHUh?=
TGBC24TKB NH22OXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUjhU2Z[UUN3ME2zMlY5OzV3IN88US=> MVvTRW5ITVJ?
LC-1F NWm3XpA3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUDN[pdwUUN3ME2zMlcyPzZ2IN88US=> M3TIVHNCVkeHUh?=
C-4-II NGK0fIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVPjZVROUUN3ME2zMlc2PjR|IN88US=> NXTrdlB1W0GQR1XS
NCI-H1650 NYHmWGRVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3rTOmlEPTB;Mz63PFQ2PSEQvF2= M1jOTHNCVkeHUh?=
JVM-2 MoroS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{nhRWlEPTB;Mz65N|Y{QSEQvF2= NX3udXdUW0GQR1XS
CaR-1 NEW2Z|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmDETWM2OD1|Lkm3OlE4KM7:TR?= MX;TRW5ITVJ?
MDA-MB-134-VI NV;me3hFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX\JR|UxRTRwMEK5OVIh|ryP M2XCSXNCVkeHUh?=
NCI-H719 NWfjOGd4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NInMNHFKSzVyPUSuNVU{QDhizszN M13IRXNCVkeHUh?=
GOTO M1[1UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml;wTWM2OD12LkK5O|A2KM7:TR?= M33OOnNCVkeHUh?=
NCI-N87 M1zPWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFvoXpBKSzVyPUSuN|g5OjFizszN M37ie3NCVkeHUh?=
NB6 NX3aO|ZiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWG2ZWt7UUN3ME20MlQzPTB7IN88US=> MlL5V2FPT0WU
DSH1 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mlm0TWM2OD12LkS3NVE3KM7:TR?= MkT0V2FPT0WU
BT-20 NFixdGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWfROJFHUUN3ME20MlQ6ODB{IN88US=> M1m5dnNCVkeHUh?=
NCI-H1882 MlP4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MY\JR|UxRTRwNUC1O{DPxE1? NIfyNpNUSU6JRWK=
WM-115 NHmxRohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4\hVWlEPTB;ND61NFg5OSEQvF2= NVyzbWt5W0GQR1XS
SKG-IIIa MlPPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmTqTWM2OD12Lk[3O|ch|ryP NWG4d3hlW0GQR1XS
NCI-H69 M3H5eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYn6coJCUUN3ME20MlcxOjd3IN88US=> NI\JenNUSU6JRWK=
MSTO-211H MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkPKTWM2OD12LkizOVY2KM7:TR?= NEjWT21USU6JRWK=
Mewo NU[1ZnVCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmLDTWM2OD12Lkm2N|E{KM7:TR?= MnfVV2FPT0WU
GI-ME-N NXTKeXd{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml7hTWM2OD13LkCwOVA6KM7:TR?= MUXTRW5ITVJ?
T98G M2OxWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVTJR|UxRTVwME[1NFgh|ryP NFXadm5USU6JRWK=
ECC4 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVXKT5luUUN3ME21MlA6Ozd{IN88US=> MUfTRW5ITVJ?
EW-11 NFO4cZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVTJR|UxRTVwMUiwPVkh|ryP NGHE[GNUSU6JRWK=
COLO-800 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFfiN2hKSzVyPUWuNVk{PDlizszN NFzhcnVUSU6JRWK=
NCI-H1755 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVrWPZFLUUN3ME21MlI{ODJ5IN88US=> MYTTRW5ITVJ?
KMS-12-PE MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkLRTWM2OD13LkO1NFg2KM7:TR?= MnLXV2FPT0WU
HCC1954 Mke1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHfKPIZKSzVyPUWuPFU6PzFizszN MlLoV2FPT0WU
NCI-H187 M2DmVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVnJR|UxRTVwOUK5PFkh|ryP NHz3OmhUSU6JRWK=
LU-165 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWXJR|UxRTVwOUmwNFIh|ryP NEnrXIdUSU6JRWK=
YAPC NYr6Z5JsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH3ZSlhKSzVyPUWuPVkxPjhizszN NV:xXop2W0GQR1XS
LU-139 NUDhSnV[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1jnU2lEPTB;Nj6wPFM3QCEQvF2= M1HuWXNCVkeHUh?=
D-502MG M{PjZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWDJR|UxRTZwM{KwOFch|ryP NH2zepRUSU6JRWK=
IST-SL1 NGrLNGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHfmSVRKSzVyPU[uOVM6PDhizszN NWexcZFwW0GQR1XS
DG-75 M2fKeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYfocndyUUN3ME22Mlg5Pzh4IN88US=> M4PNNXNCVkeHUh?=
NCI-H1155 NELXdW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUD0[2RMUUN3ME22Mlk2PThzIN88US=> MUXTRW5ITVJ?
EFE-184 NHfMV4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFi1VWtKSzVyPUeuN|E3QTVizszN M{X4[HNCVkeHUh?=
AsPC-1 NYK5ell6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYTMXIFUUUN3ME23MlQ5QDB5IN88US=> NXu5ZnJrW0GQR1XS
SW948 NGDQS|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV3KUWlCUUN3ME23MlU5Ozl3IN88US=> MYLTRW5ITVJ?
NCI-H524 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFjtTnFKSzVyPUmuOVg3OjhizszN NIHHOnVUSU6JRWK=
KOSC-2 NFSxT4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2nOXWlEPTB;OT62Nlg{PCEQvF2= NEHnXVBUSU6JRWK=
T-24 NHT6WWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYLJR|UxRTlwOUS0NVUh|ryP NFHHWFNUSU6JRWK=
NCI-H748 NULKOoRWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2PsdWlEPTB;MUCuOlM6PyEQvF2= NH3tUXhUSU6JRWK=
NCI-H23 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXjJR|UxRTFyLk[0OFIh|ryP MkGwV2FPT0WU
UACC-812 MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkLHTWM2OD1zMT63NVch|ryP NHzm[FNUSU6JRWK=
SCLC-21H M2H5T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkXRTWM2OD1zMj6xOVUyKM7:TR?= MYXTRW5ITVJ?
NCI-SNU-16 M3TFbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoSxTWM2OD1zMz6xNlU5KM7:TR?= MXnTRW5ITVJ?
HD-MY-Z NXnVb5M{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{S3SmlEPTB;MUSuOlM3OyEQvF2= M3HUe3NCVkeHUh?=
SK-N-FI NHXPNo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NY\WcHZmUUN3ME2xOE45QTF{IN88US=> MYPTRW5ITVJ?
LB647-SCLC MnLoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Moj6TWM2OD1zNT63NVk2KM7:TR?= NYfoPWJuW0GQR1XS
NCI-H345 MnHBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGfaNYxKSzVyPUG3MlM1OyEQvF2= MW\TRW5ITVJ?
NCI-H1563 MkXaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWXJR|UxRTF6Lke2NFEh|ryP MVHTRW5ITVJ?
RL NWjBd3l2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFTzUXZKSzVyPUKxMlI3PTZizszN MlTVV2FPT0WU
KY821 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXnJR|UxRTJ{LkC1OVMh|ryP MnHpV2FPT0WU
JVM-3 NX3tbYpQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3rlN2lEPTB;MkWuNFQyOyEQvF2= MlvsV2FPT0WU
NCI-H1793 NFr4e3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M161WGlEPTB;MkiuOVQ6QSEQvF2= MYHTRW5ITVJ?
LU-134-A NUjm[213T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXfJR|UxRTNyLkKwN|ch|ryP NXHOUFd5W0GQR1XS
NCI-H1395 M37mPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVfJR|UxRTN{LkK0N|Eh|ryP M{nMbnNCVkeHUh?=
NCI-H1993 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{jPR2lEPTB;M{KuPFIyQCEQvF2= MXnTRW5ITVJ?
P31-FUJ MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH\NW4lKSzVyPUOzMlQ5QTlizszN NXzLc4djW0GQR1XS
LS-513 M3vzWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX3JR|UxRTN3Lki4O|kh|ryP MkPUV2FPT0WU
SK-MEL-1 MkHBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIflVYhKSzVyPUSwMlM1QTlizszN MkPJV2FPT0WU
SW684 MlPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEn3NVlKSzVyPUSzMlk3PjFizszN Mor4V2FPT0WU
COR-L88 NVvKfpIxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3[4UmlEPTB;NESuNFY3PSEQvF2= NFvVc41USU6JRWK=
NCI-H889 NHXxfHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NImwTWNKSzVyPUS1MlAxQDdizszN Ml;BV2FPT0WU
TALL-1 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MY\JR|UxRTR4LkGxPVkh|ryP M3e3dnNCVkeHUh?=
KARPAS-299 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYLY[mE6UUN3ME20O{4yQTl|IN88US=> NHPQVXdUSU6JRWK=

... Click to View More Cell Line Experimental Data

In vivo Obatoclax also exhibits high antitumor activity in SCID mice bearing human C33A cerivical carcinoma tumors at a dose of 0.5 mg/kg. [1]

Protocol

Kinase Assay:[1]
+ Expand

Bcl-2 Binding affinity calculation:

A predicted binding affinity for Obatoclax binding to BCL-2 is calculated using the SIE scoring function. [4] As a control in determining the reliability of the calculation, predicted binding affinities Ki) are calculated for a set of 12 small molecules with experimentally measured binding affinities to BCL-2.
Cell Research:[2]
+ Expand
  • Cell lines: Human MM cells (HMCLs), peripheral blood lymphocytes (PBLs), bone marrow stromal cells (BMSCs)
  • Concentrations: ~10 μM
  • Incubation Time: 48-72 hours
  • Method: Obatoclax is dissolved in DMSO at a stock concentration of 5 mM. Cell viability is assayed by MTT. Human MM cells (HMCLs), peripheral blood lymphocytes (PBLs), bone marrow stromal cells (BMSCs) are seeded in 96-well plates at a density of 2 × 104 per well for HMCLs or 5~10 × 103 for PBLs. Various concentrations of Obatoclax are added to the cells, with or without IGF-1 (50 ng/mL) or IL-6 (10 ng/mL). Cells are incubated for 48-72 hours and cell viability is determined.
    (Only for Reference)
Animal Research:[1]
+ Expand
  • Animal Models: Female BALB/c or CB17 SCID/SCID mice bearing SW480, C33A, PC3, and 4T1 cells are used.
  • Formulation: Obatoclax (tartrate salt) is formulated in 9.6% polyethylene glycol 300, 0.4% polysorbate 20, and 5% dextrose; while for the 4T1 tumor model, Obatoclax is formulated at a concentration of 0.6 mg/mL in 9.48% polyethylene glycol, 0.38% polysorbate 20, 1.2 m
  • Dosages: 0.0313, 0.25, 0.5 and 2 mg/kg
  • Administration: Administered intravenously (tail vein) once a day
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 83 mg/mL (200.73 mM)
Water <1 mg/mL
Ethanol <1 mg/mL
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 30 mg/mL

* 1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 413.49
Formula

C20H19N3O.CH4O3S

CAS No. 803712-79-0
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT01563601 Withdrawn Extensive-stage Small Cell Lung Cancer Cephalon|Teva Pharmaceutical Industries August 2012 Phase 3
NCT01238146 Withdrawn Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Splenic Marginal Zone Lymphoma National Cancer Institute (NCI) October 2010 Phase 1|Phase 2
NCT00918931 Terminated Leukemia|Systemic Mastocytosis M.D. Anderson Cancer Center|Gemin X June 2009 Phase 2
NCT00933985 Terminated Acute Leukemias of Ambiguous Lineage|Acute Undifferentiated Leukemia|Angioimmunoblastic T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Nasal Type Extranodal NK/T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent/Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Relapsing Chronic Myelogenous Leukemia|Small Intestine Lymphoma|Unspecified Childhood Solid Tumor, Protocol Specific National Cancer Institute (NCI) June 2009 Phase 1
NCT00719901 Terminated Refractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma National Cancer Institute (NCI) July 2008 Phase 1|Phase 2
NCT00724841 Terminated Metastatic Melanoma Gemin X|Teva Pharmaceutical Industries June 2008 Phase 1|Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Bcl-2 Signaling Pathway Map

Bcl-2 Inhibitors with Unique Features

Related Bcl-2 Products

Tags: buy Obatoclax Mesylate (GX15-070) | Obatoclax Mesylate (GX15-070) supplier | purchase Obatoclax Mesylate (GX15-070) | Obatoclax Mesylate (GX15-070) cost | Obatoclax Mesylate (GX15-070) manufacturer | order Obatoclax Mesylate (GX15-070) | Obatoclax Mesylate (GX15-070) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID